TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business

Author's Avatar
Feb 21, 2023

TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or “MTAC”), today announced that James “Jim” Alecxih has joined the Company in the newly created role of President, Device Technology Business.